ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025
Machine Learning-based Prediction of Active Tuberculosis in People With HIV Using Clinical Data.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Advanced statistical approaches in tuberculosis diagnosis and treatment outcomes in Africa: a systematic review.Tropical medicine and health · 2026Review
- Predicting Tuberculosis Outcomes Using Routine Surveillance Data in Chiang Mai, Thailand: Retrospective Cohort Study.JMIR public health and surveillance · 2026Article
- Artificial Intelligence for Tuberculosis Screening and Detection: From Evidence to Policy and Implementation.Diagnostics (Basel, Switzerland) · 2026Review
- Federated Learning Performance Depends on Site Variation in Global HIV Data Consortia.medRxiv : the preprint server for health sciences · 2026Article
- Polygenic risk scores: Navigating the future of precision medicine through economic, ethical, and scientific advancements.iScience · 2026Review
- Identification of risk factors for latent tuberculosis infection in Xinjiang using machine learning.BMC public health · 2025Article
- Development of a machine learning model for early pulmonary tuberculosis diagnosis using blood test biomarkers.BMC infectious diseases · 2025Article
- Article
- HIV-1 and Artificial Intelligence: From Molecular Insight to Population Impact.Journal of AIDS and HIV treatment · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
backgroundCoinfections of Mycobacterium tuberculosis (MTB) and human immunodeficiency virus (HIV) impose a substantial global health burden. Patients with MTB infection face a heightened risk of progression to incident active TB, which preventive therapy can mitigate. Current testing methods often fail to identify individuals who subsequently develop incident active TB.
methodsWe developed random forest models to predict incident active TB using patients' medical data at HIV-1 diagnosis. Training our model involved using clinical data routinely collected at enrollment from the Swiss HIV Cohort Study (SHCS). This dataset encompassed 55 people with HIV (PWH) who developed incident active TB 6 months after enrollment and 1432 matched PWH without TB enrolled between 2000 and 2023. External validation used data from the Austrian HIV Cohort Study, comprising 43 people with incident active TB and 1005 people without TB.
resultsWe predicted incident active TB with an area under the receiver operating characteristic curve of 0.83 (95% CI: .8-.86) in the SHCS. After adjusting for ethnicity and the region of origin and refitting the model with fewer parameters, we obtained comparable receiver operating characteristic curve values of 0.72 (SHCS) and 0.67 (Austrian HIV Cohort Study). Our model outperformed the standard of care (tuberculin skin test and interferon-gamma release assay) in identifying high-risk patients, demonstrated by a lower number needed to diagnose (1.96 vs 4).
conclusionsModels based on machine learning offer considerable promise for improving care for PWH, requiring no additional data collection and incurring minimal additional costs while enhancing the identification of PWH that could benefit from preventive TB treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.